Work

Regorafenib in recurrent glioblastoma: Real-world outcomes from a Colombian cohort (REGOMA-COL).

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.2078

Authors: Javier Jacobo, Juan Esteban Garcia-Robledo, Adriana Aya, Jorge Aristizabal, Diego Pineda, Ivan Bobadilla, Alejandro Gonzalez, Julieth Montano, Jairo Andrés Zuluaga, Leonardo Rojas, Vaneza Avila, Nicolle Wagner-Gutierrez, Carolina Mantilla, Eduardo Oliveros, Natalia Sanchez, Liliana Gutiérrez, Andres Felipe Cardona

Institutions: Centro de Tratamiento e investigación sobre cáncer Luis Carlos Sarmiento Angulo, IDC Instituto de Cáncer Hemato Oncólogos, University of North Carolina at Chapel Hill

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162556607

Cites:

Cited by:

Related to: